Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action
about
Incensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animalsBi-directional effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on fear-related behavior and c-Fos expression after fear conditioning in rats.Neuropeptides, growth factors, and cytokines: a cohort of informational molecules whose expression is up-regulated by the stress-associated slow transmitter PACAP in chromaffin cellsPACAP is implicated in the stress axes.Blood BDNF level is gender specific in severe depressionStimulation of synthesis and release of brain-derived neurotropic factor from intestinal smooth muscle cells by substance P and pituitary adenylate cyclase-activating peptideVIP-induced neuroprotection of the developing brain.Seasonality and BDNF polymorphism influences depression outcome in patients with atopic dermatitis and psoriasis.Effect of social interactions on hippocampal protein expression in animal dominant and submissive model of behavioral disorders.Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors.Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells.Membrane-tethered AKT kinase regulates basal synaptic transmission and early phase LTP expression by modulation of post-synaptic AMPA receptor level.Comparative analysis of the behavioral and biomolecular parameters of four mouse strains.Endocannabinoid receptor deficiency affects maternal care and alters the dam's hippocampal oxytocin receptor and brain-derived neurotrophic factor expression.
P2860
Q28275851-5D5C1CD4-9557-420F-8185-8B1D43A09D92Q30364733-B6E7DF7B-5E12-4468-B8CE-A1FCF32039ACQ34280473-373BBC94-8378-4F77-A11F-1BC8C1C316AEQ35229429-988B2C01-6970-49B1-8411-FC49834EE8E9Q35641038-43B9E8A3-8230-42E9-873E-AB74A996F290Q35904704-FE7FD50E-B85A-4060-A7A7-29D4A4E62846Q37869518-39E42CD7-F0D3-47FF-8894-4F75B3E86F6EQ38406750-E1039F5A-CE80-4F5C-A654-2CD2322F4149Q38692694-B3D10408-65B1-440A-882A-BF0E260BE318Q38728328-084803D4-3B3C-4A52-BA1D-22CF9CCDD1F5Q39678162-C8A6681E-F9DC-48F8-BED5-0FFA43274B04Q42491700-5F1E2FD3-72EA-4E07-975B-E4F74260ABDBQ42601704-9045CF23-8760-46EC-A24F-280BEFDE894AQ46117249-CF833779-B293-4375-BCD7-4199B5BD9829
P2860
Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action
description
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
scientific journal article
@en
vedecký článok (publikovaný 2008/11/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/11/01)
@nl
наукова стаття, опублікована в листопаді 2008
@uk
مقالة علمية (نشرت في نوفمبر 2008)
@ar
name
Involvement of pituitary adeny ...... anism of antidepressant action
@ast
Involvement of pituitary adeny ...... anism of antidepressant action
@en
Involvement of pituitary adeny ...... anism of antidepressant action
@nl
type
label
Involvement of pituitary adeny ...... anism of antidepressant action
@ast
Involvement of pituitary adeny ...... anism of antidepressant action
@en
Involvement of pituitary adeny ...... anism of antidepressant action
@nl
prefLabel
Involvement of pituitary adeny ...... anism of antidepressant action
@ast
Involvement of pituitary adeny ...... anism of antidepressant action
@en
Involvement of pituitary adeny ...... anism of antidepressant action
@nl
P1476
Involvement of pituitary adeny ...... anism of antidepressant action
@en
P2093
Michal Reichenstein
Moshe Rehavi
P2888
P304
P356
10.1007/S12031-008-9116-0
P577
2008-11-01T00:00:00Z
P5875
P6179
1035108461